About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey.

Learn more
Join Putnam
Insights

Contact

Donna Fountain

Partner, Market Access

Donna leads the scientific function of the market access team at Putnam, who specialize in evidence synthesis and medical writing to support HTA submissions and market access strategy, as well as global value dossier development, stakeholder engagement, reimbursement and landscape mapping, and peer-review manuscript development.

Donna has extensive knowledge of multiple therapeutic areas, including oncology, chronic kidney disease, gastrointestinal disorders, cardiovascular disease, age-related disease, and orphan diseases. Donna has also published her research in peer-reviewed journals and presented work at multiple international conferences.

Donna has a BSc in Biomedical Science, MSc in Biological Sciences, and PhD in Health Sciences from the University of Nottingham.

Other members.

Antonio Iervolino

Shauna Collins

Chief Financial Officer

Elaine Nguyen

Life Sciences Consultant

Michael Harvey